Input of magnetic resonance spectroscopy in gliomas explorations;Apports de la spectroscopie par résonance magnétique dans l'exploration des gliomes

Bulletin du Cancer

Volumn 92, Issue 4, 2005, Pages 327-331

  Galanaud, Damien ^a,b   Chinot, Olivier ^c,d   Metellus, Philippe ^c   Cozzone, Patrick ^a  

^a University of Aix Marseille   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Diagnosis; Glioma; Magnetic resonance spectroscopy

Indexed keywords

ADRENOMEDULLIN; TUMOR MARKER;

ARTICLE; BRAIN LYMPHOMA; BRAIN METABOLISM; CANCER GRADING; CELL SPECIFICITY; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GLIOMA; GLIOSIS; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTITATIVE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE; BRAIN TUMOR; METABOLISM; METHODOLOGY; REVIEW;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; TUMOR MARKERS, BIOLOGICAL;

EID: 18344364873     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001; 205: 54-84.
2. Law M, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002; 222: 715-21.
3. De Edelenyi FS, et al. A new approach for analyzing proton magnetic resonance spectroscopic images of brain rumors: nosologic images. Nat Med 2000; 6: 1287-9.
4. Poptani H, et al. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 1995; 16: 1593-603.
5. Guzman R, et al. Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain process from cystic brain tumors. J Neurosurg 2002; 97: 1101-7.
6. Grand S, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy-initial results. Radiology 1999; 21: 785-93.
7. Ebisu T, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996; 14: 1113-6.
8. Herminghaus S, et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 2003; 98: 74-81.
9. Law M, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003; 24: 1989-98.
10. Castillo M, Keith Smith J, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000; 21: 1645-9.
11. Coons S, et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997; 79: 1381-93.
12. Li X, et al. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004; 17: 10-20.
13. Oh J, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004; 19: 546-54.
14. Kuznetsov YE, et al. Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 2003; 53: 565-74 [discussion: 574-6].
15. Galanaud D, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003; 98: 269-73.
16. Walecki J, et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol 2003; 10: 145-53.
17. Pirzkall A, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002; 53: 1254-64.
18. Nelson SJ, et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002; 16: 464-76.
19. Pirzkall A, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004; 59: 126-37.
20. Cairncross JG, Pexman JH, Rarhbone MP. Post-surgical contrast enhancement mimicking residual brain tumour. Can J Neurol Sci 1985; 12: 75.
21. Rabinov JD, et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225: 871-9.
22. Rock JP, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51: 912-9 [discussion: 919-20].
23. Graves EE, et al. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neuroradiol 2001; 22: 613-24.
24. Murphy PS, et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Br J Cancer 2004; 90: 781-6.